Treating Amblyopia with a Hydrogel Patch
Drug Topics
OCTOBER 24, 2022
According to NEXGEL, the patch is expected be available for ophthalmologists to offer to their patients in the first half of 2023.
Mon.Oct 24, 2022
185 
The law driving technology transfer and fostering innovation
PhRMA
OCTOBER 24, 2022
The bipartisan Bayh-Dole Act created a framework for researchers receiving federal funds to patent and license their inventions to companies for further development and commercialization. This benefits innovators across many sectors.
Join 18,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Power in Numbers
Drug Topics
OCTOBER 24, 2022
Flip the Pharmacy helped this Jonesboro, Arkansas, pharmacy go from a traditional dispensing one to a pharmacy offering robust clinical services.
Central Nervous System Infection Is Common in Multiple Strains of Herpesvirus
Pharmacy Times
OCTOBER 24, 2022
Researchers conducted a review all 8 herpesviruses and their known treatments and found patients experienced encephalitis or another CNS symptom in almost every strain.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Hospitalization, Mortality Benefits Seen in Vaccinated Patients Who Took Paxlovid
Drug Topics
OCTOBER 24, 2022
Findings by researchers at Epic, the electronic health record company, show that the benefits extend to people ages 50-64.
Overview of SARS-CoV-2 Virus and Subvariants
Pharmacy Times
OCTOBER 24, 2022
Jacinda Abdul-Mutakabbir, PharmD, discusses the difference between the original SARS-CoV-2 strain and subvariant strains.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Bacterium in the Gut Could be a Biomarker to Predict the Severity of COVID-19 Symptoms
Pharmacy Times
OCTOBER 24, 2022
A researcher suggests that the levels of certain gut bacteria can predict the severity of symptoms that someone can experience when infected with COVID-19.
Fruth Pharmacy celebrates 70 years in business
Drug Store News
OCTOBER 24, 2022
A celebration of business for Fruth Pharmacy is also a celebration of the life of Jack Fruth and his gifts to the local communities which it continues to serve.
COVID-19 PCR Test Receives FDA Clearance for use on Cobas Systems
Pharmacy Times
OCTOBER 24, 2022
The test has been available under emergency use authorization (EUA) since March of 2020 and was the first commercial molecular test to receive EUA status.
Point-of-Care Testing 101: Get Started Today
Drug Topics
OCTOBER 24, 2022
Turn your pharmacy into a point-of-care testing site.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Accelerating Specialty Prescribing Through Automation
Pharmacy Times
OCTOBER 24, 2022
Automation can lessen the administrative burden on providers and accelerate specialty prescribing and dispensing to provide patients with quality care the moment they need it.
Tree Hut’s Holidaze collection preps skin for the holiday season
Drug Store News
OCTOBER 24, 2022
Tree Hut’s Holidaze collection features holiday-centric Shea Sugar Scrubs, as well as a Whipped Body Butter and Bare Moisturizing Shave Oil.
Study: Health Care Providers May Perpetuate Racial Disparities in Heart Failure Treatment
Pharmacy Times
OCTOBER 24, 2022
Black adults are suggested to have an increased risk of heart failure, which highlights the need for equitable treatment and decision-making.
Amazon to accept Venmo payments
Drug Store News
OCTOBER 24, 2022
In time for the holidays, customers will be able to place an order using Venmo as their payment method on Amazon.com and the Amazon mobile app.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Technicians Discuss Different Continuing Education Requirements Across the World
Pharmacy Times
OCTOBER 24, 2022
In a panel, pharmacy technicians across the world discuss the different continuing educations requirements in United States, Portugal, and the United Kingdom.
Treatment Adherence Strategies for Patients with Diabetes
Drug Topics
OCTOBER 24, 2022
Jennifer D. Goldman, RPh, PharmD, CDCES, BC-ADM, FCCP, explores strategies to increase patient adherence to treatment.
Previous Non-Omicron SARS-CoV-2 Infection May Protect Against Infection of Omicron
Pharmacy Times
OCTOBER 24, 2022
Prior infection with SARS-CoV-2 decreased the risk of being reinfected with Omicron among unvaccinated and vaccinated individuals.
RWE There Yet? FDA’s New Pilot Program Seeks to Help Usher in a New Era for Real World Evidence
The FDA Law Blog
OCTOBER 24, 2022
By Mark A. Tobolowsky — Making use of real-world data has long been of interest to stakeholders as having tremendous potential value. These data are routinely collected from a variety of sources, such as electronic health records, providing information on health and healthcare in actual patients, rather than in the controlled environment of a clinical trial.
Bausch + Lomb enters pet health care space
Drug Store News
OCTOBER 24, 2022
Project Watson’s products were formulated to help support dogs’ eyes, ears and overall well-being, the company said.
Women and men are different, cardiovascular edition
STAT
OCTOBER 24, 2022
It’s quite the task to photograph someone’s heart while they’re exercising. They have to lie on their back in a pressure-controlled chamber, riding a suspended stationary bike while an ultrasound imager points at their pumping heart — at least that’s how one group of researchers from the University of Calgary and Hong Kong went about it.
Walgreens partners with DoorDash, Uber Health to provide free Paxlovid delivery
Drug Store News
OCTOBER 24, 2022
Free delivery will help accelerate access to COVID-19 treatment for underserved U.S. populations, Walgreens said.
Opinion: Keeping families out of ICUs no longer makes sense as the pandemic eases
STAT
OCTOBER 24, 2022
On, December 9, 2020, my mom, brother, and I waited in a cold, wintery drizzle outside the local hospital in my hometown in southern Colorado, anxiously hoping to be allowed to see my dad for the last time. After contracting Covid-19, he had been in the intensive care unit (ICU) for nearly a month and his condition had deteriorated to the point that we were summoned to the hospital to say our goodbyes.
The Increasing Prevalence of Diabetes
Drug Topics
OCTOBER 24, 2022
Jerry Meece, RPh, CDCES, FACA, FADCES, initiates a discussion around the increasing prevalence of patients diagnosed with diabetes.
Expert: ‘We Are Having Outbreaks of Vaccine-Preventable Diseases,’ Need to Be Aware of Current Indications
Pharmacy Times
OCTOBER 24, 2022
An ASCP 2022 session presenter explains some recent updates on vaccination guidance for the older adult population.
STAT+: Epic’s overhaul of a flawed algorithm shows why AI oversight is a life-or-death issue
STAT
OCTOBER 24, 2022
Epic, the nation’s dominant seller of electronic health records, was bracing for a catastrophe. It was June 2021, and a study about to be published in the Journal of the American Medical Association had found that Epic’s artificial intelligence tool to predict sepsis, a deadly complication of infection, was prone to missing cases and flooding clinicians with false alarms.
Novartis’ oral drug iptacopan tops injectables in head-to-head PNH trial
pharmaphorum
OCTOBER 24, 2022
Novartis has chalked up another clinical trial win for its targeted factor B inhibitor iptacopan as it strives to position the drug as a patient-friendly, oral alternative to big-selling injectable rivals. The least positive readout comes from the APPLY-PNH study, which pitted iptacopan against AstraZeneca/Alexion’s anti-C5 antibodies Soliris (eculizumab) and Ultomiris (ravulizumab) in adults with paroxysmal nocturnal haemoglobinuria (PNH), a debilitating ultra-rare blood disorder in which
Opinion: Better access to PET scans can help reduce racial inequities in Alzheimer’s disease
STAT
OCTOBER 24, 2022
While many Americans are familiar with the devastating impact of Alzheimer’s disease, few understand the cruel disparity with which it strikes. Black Americans are twice as likely to be diagnosed with this mind-robbing disease and bear the greatest costs of caring for loved ones suffering with it. Alzheimer’s was historically diagnosed based on symptoms, and only confirmed with an autopsy.
Trying to get clarity on CDF and VPAS and implications for the IMF
pharmaphorum
OCTOBER 24, 2022
Companies who are thinking about seeking funding via England’s new Innovative Medicines Fund (IMF) need to think through all the commercial implications, including whether spending in the IMF counts towards rebates made against sales through the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS). With the IMF not yet used, but based on the Cancer Drugs Fund (CDF), Leela Barham used a freedom of information request to find out how the CDF spend is treated, and speculates as to what
STAT+: Pharmalittle: Merck suddenly finds Ebola vaccine doses in its freezers; drugs studied to combat women’s midlife mood swings
STAT
OCTOBER 24, 2022
Good morning, everyone, and welcome to another working week. We hope the weekend respite was relaxing and invigorating, because that oh-so familiar routine of phone calls, online meetings, and deadlines has predictably returned. But what can you do? The world, such as it is, keeps spinning. So time to give it a nudge in a useful direction with a cup or three of stimulation.
FDA Approvals: September 2022 Recap
Digital Pharmacist
OCTOBER 24, 2022
Innovation drives progress. When it comes to innovation in the development of new drugs and therapeutic biological products in the pharmaceutical industry, the United States Food and Drug Administration’s (FDA’s) Center for Drug Evaluation and Research (CDER) is a key supporter of the pharmaceutical industry. . CDER relies on its understanding of science and regulatory procedures to support and provide advice to pharmaceutical companies in testing and manufacturing, to then bring these new ther
Steep drop for UK industry clinical trials between 2017 and 2021
European Pharmaceutical Review
OCTOBER 24, 2022
The number of industry clinical trials initiated in the UK, per year, fell by 41 percent from 2017 to 2021, according to the latest annual report on clinical research from the Association of the British Pharmaceutical Industry ( ABPI ). The report ‘Rescuing Patient Access to Industry Clinical Trials in the UK’ stated that patient care, the NHS, and economic growth are all declining because of this collapse.
Checking the box on digital engagement isn’t enough
PharmaVoice
OCTOBER 24, 2022
In a recent study, 50% of healthcare consumers reported that a bad digital experience with their provider ruined the entire experience, while 39% felt that a good digital interaction had a positive influence.
Sumitomo ups ante and wins support for Myovant takeover
pharmaphorum
OCTOBER 24, 2022
A sweetened offer from Sumitomo Pharma has convinced endocrinology specialist Myovant to agree to a takeover, after its first was rejected. Sumitomo and its subsidiary Sumitovant Biopharma initially offered $22.75 for Myovant – which develops hormonal therapies for conditions like uterine fibroids, endometriosis and prostate cancer – but that was deemed inadequate and was turned down earlier this month.
Biosimilars will gain ground in 2023 with Humira launches — and that’s just the beginning
PharmaVoice
OCTOBER 24, 2022
In Amgen's 2022 Biosimilars Trend Report, the company tracks the progress and potential of the copycat drugs as they reach a pivotal moment.
Let's personalize your content